2013 American Transplant Congress
Efficacy of Everolimus with Reduced Cyclosporine in Japanese De Novo Renal Transplant Recipients: 24-Month, Randomized, Multicenter Study
Introduction: Results from study A1202 showed that everolimus (EVR) plus reduced dose cyclosporine (rCsA) prevents acute rejection, preserves renal function, and reduces incidence of viral…2013 American Transplant Congress
Positive Flow Crossmatches in Renal Patients without “Detectable” Anti-Donor HLA Antibodies; Maximizing Renal Transplant Rate by Decreasing False Positive Crossmatches
HLA Laboratory and the Transplant Center, Lehigh Valley Health Network, Allentown, PA
A recurring problem in recipient selection for deceased donor renal transplantation is a positive crossmatch in a “non-donor antigen sensitized “individuals. We initiated a study…2013 American Transplant Congress
Suppression of Acute Rejection by Administration of Prostaglandin E2 Receptor Subtype 4 (EP4) Agonist in a Rat Heterotopic Small Bowel Transplantation Model
Background: Prostaglandin E2 (PGE2)–PGE2 receptor subtype 4 (EP4) signaling is known to modulate the inflammation process. Several studies have demonstrated the potential utility of EP4-selective…2013 American Transplant Congress
Kidney Injury Molecule-1 and Osteopontin: New Markers for Prediction of Early Kidney Transplant Rejection
Background. Kidney injury molecule-1 (KIM-1) and osteopontin (OPN) play important roles in immune regulation. We hypothesized that serum KIM-1 and OPN might serve as biomarkers…2013 American Transplant Congress
Health-Related Quality of Life and Adherence to Medication in Kidney Transplantation: A Longitudinal Analysis
AimTo analyse the influence of dialysis type on adherence to immunosupressive medications (IS) and HRQoL before and after KT.Material and Methods. Between years 2004-2008 156…2013 American Transplant Congress
Impact of Vitamin D, Bisphosphonate, and Combination Therapy on Bone Mineral Density in Kidney Transplant Patients
Background: Osteoporosis can develop and become aggravated in a large number of kidney transplant patients; however, the best preventive options for post-transplant osteoporosis remain controversial.Methods:…2013 American Transplant Congress
Multicenter Evaluation of Efficacy and Safety of Valganciclovir 450 mg/day vs. 900 mg/day for Prevention of Cytomegalovirus Disease in Donor and Recipient Positive (D+/R+) Renal Transplant Recipients
Multicenter CMV Pharmacists Collaborative Study Group, Boston
The cytomegalovirus (CMV) donor-positive/recipient-positive (D+/R+) population represents the largest proportion of renal transplant recipients (RTR). Current practice guidelines on the prevention of CMV recommend antiviral…2013 American Transplant Congress
Utility of Serial Allograft Biopsies (AGBx) during Delayed Graft Function (DGF) in Renal Transplantation, The
Renal Transplant Center, Henry Ford Hospital, Detroit, MI
Background: DGF complicates approximately 30% of deceased donor (DD) kidney transplants and rarely also occurs following live donor (LD) kidney transplants (KTX). KTX in DGF…2013 American Transplant Congress
Using Non-Invasive, Real-Time Imaging Technology To Assess the Status of Donor Kidneys
Purpose. The extent of acute tubular necrosis (ATN) in renal tubules may provide valuable prognostic data regarding post-transplant renal function of donor kidneys. We used…2013 American Transplant Congress
Flow Crossmatching for Renal Transplantation in the Virtual Crossmatch Era: Fifty Shades of Grey
HLA Laboratory and the Transplant Center, Lehigh Valley Health Network, Allentown, PA
Every transplant team wants a definitive answer for the compatibility of a potential recipient with a specific donor. The Mean Equivalent Standard Fluorescence is a…
- « Previous Page
- 1
- …
- 139
- 140
- 141
- 142
- 143
- …
- 178
- Next Page »